Hepatocellular carcinoma in hereditary tyrosinemia type I despite 2-(2 nitro-4-3 trifluoro- methylbenzoyl)-1, 3-cyclohexanedione treatment.
van Spronsen
Francjan J
FJ
Section of Metabolic Diseases, Beatrix Children's Hospital, University Medical Center of Groningen, The Netherlands. f.j.van.spronsen@bkk.azg.nl
Bijleveld
Charles M A
CM
van Maldegem
Bianca T
BT
Wijburg
Frits A
FA
D006528:Carcinoma, Hepatocellular / Q000209:etiology* / Q000235:genetics / Q000628:therapy; D002675:Child, Preschool; D003512:Cyclohexanones / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D008113:Liver Neoplasms / Q000209:etiology* / Q000235:genetics / Q000628:therapy; D016031:Liver Transplantation; D008297:Male; D009579:Nitrobenzoates / Q000627:therapeutic use; D016896:Treatment Outcome; D020176:Tyrosinemias / Q000150:complications* / Q000235:genetics / Q000628:therapy
D003512:Cyclohexanones; D004791:Enzyme Inhibitors; D009579:Nitrobenzoates